- Home
- TAK vs AME Comparison
TAK vs AME Comparison
Compare TAK & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- AME
- Stock Information
- Founded
- TAK 1781
- AME 1930
- Country
- TAK Japan
- AME United States
- Employees
- TAK N/A
- AME N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- AME Industrial Machinery/Components
- Sector
- TAK Health Care
- AME Industrials
- Exchange
- TAK Nasdaq
- AME Nasdaq
- Market Cap
- TAK 47.0B
- AME 38.6B
- IPO Year
- TAK N/A
- AME N/A
- Fundamental
- Price
- TAK $14.37
- AME $171.81
- Analyst Decision
- TAK
- AME Buy
- Analyst Count
- TAK 0
- AME 9
- Target Price
- TAK N/A
- AME $200.13
- AVG Volume (30 Days)
- TAK 2.0M
- AME 1.2M
- Earning Date
- TAK 05-08-2025
- AME 05-01-2025
- Dividend Yield
- TAK 4.08%
- AME 0.72%
- EPS Growth
- TAK N/A
- AME 7.39
- EPS
- TAK 0.45
- AME 6.11
- Revenue
- TAK $30,595,075,281.00
- AME $6,936,971,000.00
- Revenue This Year
- TAK $0.87
- AME $3.51
- Revenue Next Year
- TAK $1.69
- AME $5.44
- P/E Ratio
- TAK $63.69
- AME $28.08
- Revenue Growth
- TAK 7.45
- AME 2.98
- 52 Week Low
- TAK $12.58
- AME $145.02
- 52 Week High
- TAK $15.37
- AME $198.33
- Technical
- Relative Strength Index (RSI)
- TAK 40.48
- AME 57.59
- Support Level
- TAK $14.22
- AME $167.75
- Resistance Level
- TAK $15.43
- AME $173.72
- Average True Range (ATR)
- TAK 0.20
- AME 3.37
- MACD
- TAK -0.08
- AME 1.34
- Stochastic Oscillator
- TAK 11.98
- AME 89.49
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About AME AMETEK Inc.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.